Low-risk DCIS patients may safely skip radiotherapy after surgery, study finds

Patients with low-risk ductal carcinoma in situ (DCIS) who skipped adjuvant radiotherapy after breast-conserving surgery had comparable five-year outcomes to those with high-risk DCIS who received adjuvant radiotherapy, according to results from the E4112 clinical trial presented at the San Antonio Breast Cancer Symposium, held December 5-9, 2023.

Sales of emergency contraception estimated to rise after the New Year holiday

Sales of emergency contraception are estimated to rise by around 10% in the US in the week after the New Year holiday, suggesting that this

December 22, 2023

New research highlights potential of cytisine for global smoking cessation efforts

A new study published in Addiction has found that cytisine, a low-cost, generic stop-smoking aid that has been used in eastern Europe since the 1960s,

January 2, 2024

Federal judge extends restraining order on Trump administration’s cap on NIH indirect costs

BOSTON — After two hours of arguments from the Trump administration and three sets of plaintiffs, a federal judge on Friday kept in place an order

February 21, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.